| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $185.7M | -28.3% |
| Cost of Revenue | $151.8M | +0.6% |
| Gross Profit | $34.0M | -68.6% |
| R&D Expense | $17.4M | -9.5% |
| SG&A Expense | $145.1M | -10.3% |
| Operating Income | -$215.3M | +8.6% |
| Pre-tax Income | -$235.0M | +10.1% |
| Income Tax | -$4.2M | -126.5% |
| Net Income | -$130.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $216.9M | -32.7% |
| Accounts Receivable | $25.5M | -33.8% |
| Inventory | $40.5M | -19.1% |
| Current Assets | $296.3M | -31.0% |
| Total Assets | $770.6M | -23.6% |
| Current Liabilities | $44.9M | -21.2% |
| Long-term Debt | $291.8M | -1.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.6M | -871.2% |
| Capital Expenditures | $13.1M | -55.7% |
| Investing Cash Flow | -$31.4M | -29.2% |
| Financing Cash Flow | -$16.5M | +93.0% |
| Free Cash Flow | -$70.7M | -218.7% |
| +9.7% |
| EPS (Basic) | -$0.90 | +14.3% |
| EPS (Diluted) | -$0.90 | +14.3% |
| Total Liabilities |
| $397.9M |
| -7.7% |
| Stockholders' Equity | $212.4M | -34.7% |